Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of Pacific Biosciences (Nasdaq: PACB) jumped 10% in early trading today.

So what: Scientists from Harvard and Pacific Biosciences have decoded a genome of the cholera pathogen in Haiti. The data suggest people brought this outbreak to Haiti from South Asia.

Now what: What is impressive about this is it took only two days for Pacific Biosciences to map the genome. This speed will allow scientists to quickly act in preventing future cholera outbreaks and shows the company's ability to get results quickly. The market has settled down after a spike early in the day, and I would like to see some financial impact before thinking Pacific Biosciences would go higher beyond this news.

Interested in more info on Pacific Biosciences? Add it to your watchlist.

Fool contributor Travis Hoium does not have a position in any company mentioned. You can follow Travis on Twitter at @FlushDrawFool, check out his personal stock holdings or follow his CAPS picks at TMFFlushDraw.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.